Mkts

Aclaris Therapeutics, Inc.

NASDAQ: ACRS
$3.92-0.08 (-2.00%)
As of Nov 13, 4:00 PM ET

Key statistics

Day range
3.773.99
52-week range
2.256.60
Today
Open3.98
Previous close3.92
Volume2.46M
Valuation
Market cap655.07M
P/E ratio—
EPS (TTM)-0.59
Income & risk
Dividend / yield—
Beta0.93
Avg volume2.62M
Discussion

ACRS News

Stories mentioning ACRS from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,9961,2953,2991,7771,4559,2104,3462,766
Cost of Goods Sold395.00532.00538.00515.00506.00705.00654.00624.00
Gross Profit1,601763.002,7611,262949.008,5053,6922,142
Operating Expenses
Research & Development15,65716,58413,02811,44911,5849,0265,9568,759
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(22,192)(22,734)(17,149)(18,408)(18,084)(99,676)(10,471)(12,854)
Interest Income1,5141,6341,8192,0182,1662,1041,9911,868
Interest Expense
Other Expense1,868
Pretax Income(19,795)(14,614)(15,429)(15,085)(96,552)(7,586)(10,986)
Tax Provision
Net Income (Loss)(19,824)(19,795)(14,614)(15,429)(15,085)(96,552)(7,586)(10,986)
Earnings Per Share (Basic)(0.15)(0.16)(0.12)(0.13)(0.12)(1.25)(0.11)(0.15)
Earnings Per Share (Diluted)(0.15)(0.16)(0.12)(0.13)(0.12)(1.25)(0.11)(0.15)
Weighted Average Shares Outstanding (Basic)128,810122,565122,619122,581122,39077,29771,38271,291
Weighted Average Shares Outstanding (Diluted)128,810122,565122,619122,581122,39077,29771,38271,291

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ACRS

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) is a stock listed on the Nasdaq Stock Market under the ticker symbol ACRS. It last traded at $3.92 (Nov 13, 2026, 4:00 PM ET), down 2.0% on the day. That gives Aclaris Therapeutics a market capitalisation of $655.1M.

Over the past 52 weeks ACRS has traded between $2.25 and $6.60.

Revenue for the quarter ended Mar 31, 2026 was $2.0M; a net loss of $19.8M. Revenue was up 37.2% from $1.5M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$2.0M-$19.8M-993.2%
Dec 31, 2025$1.3M-$19.8M-1528.6%
Sep 30, 2025$3.3M-$14.6M-443.0%
Jun 30, 2025$1.8M-$15.4M-868.3%

From Aclaris Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…